The procedure, conducted under the Abu Dhabi Bone Marrow Transplant Program (AD-BMT®), involved treating Salah Al Farawi, whose condition resulted from a mutation in the MAP3K14 gene.

UAE—Yas Clinic Khalifa City and Abu Dhabi Stem Cells Center (ADSCC) have successfully performed the world’s fifth reported bone marrow transplant for NIK deficiency, treating a 10-year-old Yemeni patient with a rare inherited immune disorder.
The procedure, conducted under the Abu Dhabi Bone Marrow Transplant Program (AD-BMT®), involved treating Salah Al Farawi, whose condition resulted from a mutation in the MAP3K14 gene.
The disorder severely weakens the immune system, leaving patients vulnerable to recurrent and potentially life-threatening infections.
Transplant addresses underlying immune deficiency
Salah’s medical history included repeated hospital admissions, severe cytomegalovirus (CMV) infections affecting his eye, gastrointestinal tract and bloodstream, and Epstein-Barr virus (EBV) infection.
He also developed Cryptosporidium infection, which caused persistent diarrhoea, significant weight loss and impaired growth.
Although doctors controlled the individual infections through medical treatment, his underlying genetic condition continued to compromise his immune system.
A bone marrow transplant was therefore necessary to establish a functioning donor-derived immune system.
Following compatibility testing, his 19-year-old brother was identified as a fully matched donor.
The multidisciplinary AD-BMT® team subsequently performed an allogeneic bone marrow transplant.
After the procedure, Salah achieved full donor chimerism, indicating that donor-derived blood and immune cells had successfully established themselves.
He has since recovered, shows no signs of active infection and has returned home in good health.
Two of his siblings had previously died from severe infections associated with the same inherited disorder.
Expanding specialist transplantation capabilities
Dr Maysoon, Chief Medical Officer at Yas Clinic, said the procedure demonstrates Abu Dhabi’s capacity to manage complex inherited immune disorders through specialized diagnostics, transplantation and multidisciplinary care.
She noted that the programme integrates transplantation expertise, cellular therapies and laboratory capabilities to expand access to advanced treatments locally.
The experience gained from complex cases also supports the development of precision medicine and specialized clinical services.
Dr Mansi, Clinical Lead and Consultant in Paediatric Haematology, Oncology and Bone Marrow Transplantation, said identifying Salah’s brother as a fully matched donor enabled the team to address the underlying immune deficiency rather than continue treating individual infections.
She highlighted the importance of accurate genetic diagnosis and timely access to transplantation for children with severe inherited immunodeficiencies.
MAP3K14 encodes NF-κB-inducing kinase (NIK), a protein involved in immune system development and regulation.
Disease-causing mutations can disrupt immune function, increasing susceptibility to bacterial, viral and other serious infections. The condition’s rarity has limited global clinical experience with transplantation as a treatment option.
Integrated model combines clinical and laboratory expertise
The AD-BMT® programme provides adult and paediatric transplantation and cellular therapy services for malignant and non-malignant conditions, including blood cancers, bone marrow disorders, inherited blood diseases and immune deficiencies.
Yas Clinic Khalifa City provides clinical and transplantation services, while ADSCC contributes laboratory, scientific and research capabilities.
Their partnership supports an integrated treatment pathway covering genetic diagnosis, patient assessment, donor selection, transplantation and long-term follow-up.
Be the first to leave a comment